Effect of discontinuation of lemborexant following long‐term treatment of insomnia disorder: Secondary analysis of a randomized clinical trial-Reference-Cited by-同舟云学术

Effect of discontinuation of lemborexant following long‐term treatment of insomnia disorder: Secondary analysis of a randomized clinical trial

Author:

Takaesu Yoshikazu¹,Suzuki Masahiro²,Moline Margaret³,Pinner Kate⁴,Inabe Kanako⁵,Nishi Yurie⁵,Kuriyama Kenichi⁶

Affiliation:

1. Department of Neuropsychiatry, Graduate School of Medicine University of the Ryukyus Okinawa Japan

2. Department of Psychiatry Nihon University School of Medicine Tokyo Japan

3. Eisai Inc. Nutley New Jersey USA

4. Eisai Ltd. Hatfield UK

5. Eisai Co., Ltd. Tokyo Japan

6. Department of Sleep‐Wake Disorders, National Institute of Mental Health National Center of Neurology and Psychiatry Tokyo Japan

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

Reference27 articles.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

5. Emerging and upcoming therapies in insomnia;Translational and Clinical Pharmacology;2024